| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Vamsi Krishna Lavu, Rana Abdelwahab Mohamed, Ruimin Huang, Shanthi Potla, Sushen Bhalla, Yousif Al Qabandi, Savitri Aninditha Nandula, Chinmayi Sree Boddepalli, Sai Dheeraj Gutlapalli, Lubna Mohamme. Evaluation and Treatment of Depression in Stroke Patients: A Systematic Review. Cureus. vol 14. issue 8. 2022-09-22. PMID:36134047. |
according to pooled studies, the risk of acquiring post-stroke depression (psd) was lower in participants undergoing pharmacological therapy with selective serotonin reuptake inhibitors (ssris), especially after a year. |
2022-09-22 |
2023-08-14 |
human |
| Anna L Arzuaga, Daisy D Edmison, Jessica Mroczek, John Larson, Michael E Ragozzin. Prenatal Stress and Fluoxetine Exposure in Mice Differentially Affect Repetitive Behaviors and Synaptic Plasticity in Adult Male and Female Offspring. Behavioural brain research. 2022-09-18. PMID:36116737. |
selective serotonin reuptake inhibitor (ssri) treatment can be effective in alleviating maternal depression but prenatal ssri exposure itself may be a risk factor for autism in offspring. |
2022-09-18 |
2023-08-14 |
mouse |
| Rahul Chikatimalla, Thejaswi Dasaradhan, Jancy Koneti, Swathi Priya Cherukuri, Revanth Kalluru, Sai Gadd. Depression in Parkinson's Disease: A Narrative Review. Cureus. vol 14. issue 8. 2022-09-15. PMID:36106206. |
this article also explored the pharmacological treatment of depression in pd; this involves standard antidepressant therapy such as tricyclic antidepressants (tca), serotonin-norepinephrine reuptake inhibitors (snri), selective serotonin reuptake inhibitors (ssri), and monoamine oxidase inhibitors (mao); non-pharmacological treatments such as electroconvulsive therapy (ect), cognitive-behavioral therapy (cbt) have also been discussed. |
2022-09-15 |
2023-08-14 |
Not clear |
| Young Kyung Moon, Hyeseung Kim, Seonwoo Kim, Shinn-Won Lim, Doh Kwan Ki. Influence of antidepressant treatment on SLC6A4 methylation in Korean patients with major depression. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2022-09-12. PMID:36094099. |
genetic variation of the serotonin transporter gene (slc6a4) has been suggested as potential mediator for antidepressant response in patients with depression. |
2022-09-12 |
2023-08-14 |
Not clear |
| Young Kyung Moon, Hyeseung Kim, Seonwoo Kim, Shinn-Won Lim, Doh Kwan Ki. Influence of antidepressant treatment on SLC6A4 methylation in Korean patients with major depression. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2022-09-12. PMID:36094099. |
overall, 221 korean patients with depression completed 6 weeks of selective serotonin reuptake inhibitor (ssri) monotherapy. |
2022-09-12 |
2023-08-14 |
Not clear |
| Abdelkader Dahchou. Anxiolytic and antidepressive potentials of rosmarinic acid: A review with focus on antioxidant and anti-inflammatory effects. Pharmacological research. 2022-09-12. PMID:36096427. |
anxiolytic and antidepressant drugs, such as benzodiazepines, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, and tricyclics, are the first line used in treating anxiety and depression. |
2022-09-12 |
2023-08-14 |
Not clear |
| Devan Mehta, Abhishek Ganta, Vivian Bradaschia-Correa, Sanjit R Konda, Kenneth A Egol, Philipp Leuch. Clinical Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) on Fracture Healing. Bulletin of the Hospital for Joint Disease (2013). vol 80. issue 3. 2022-08-28. PMID:36030445. |
chronic use of selective serotonin reuptake inhibitors (ssris) for the treatment of depression has been linked to an imbalance in bone metabolism leading to osteoporosis. |
2022-08-28 |
2023-08-14 |
Not clear |
| Surya P Nuguru, Sriker Rachakonda, Shravani Sripathi, Mashal I Khan, Naomi Patel, Roja T Med. Hypothyroidism and Depression: A Narrative Review. Cureus. vol 14. issue 8. 2022-08-25. PMID:36003348. |
studies have demonstrated that somatostatin and serotonin influence the hypothalamus-pituitary-thyroid axis, which links hypothyroidism to depression. |
2022-08-25 |
2023-08-14 |
Not clear |
| Nicholas Barreras, Christine Feld, Israel Rubinstei. Does hypoxemia contribute to treatment-resistant depression in patients with COPD by decreasing serotonin synthesis in the brain? Journal of affective disorders. 2022-08-25. PMID:36007590. |
does hypoxemia contribute to treatment-resistant depression in patients with copd by decreasing serotonin synthesis in the brain? |
2022-08-25 |
2023-08-14 |
Not clear |
| Yiyue Zhu, Jiaru He, Canwen Wu, Junwei Wu, Zhongwen Cheng, Yan Chen, Maodan Yuan, Lvming Zeng, Xuanrong J. Transcranial ultrasound stimulation relieves depression in mice with chronic restraint stress. Journal of neural engineering. 2022-08-23. PMID:35998565. |
exhaustion of serotonin (5-hydroxytryptamine, 5-ht) is a typical cause of the depression disorder's development and progression, including depression-like behaviors. |
2022-08-23 |
2023-08-14 |
mouse |
| Zhuoyue Wang, Hui Li, Yimin Kang, Yanlong Liu, Ligang Shan, Fan Wan. Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis. Therapeutics and clinical risk management. vol 18. 2022-08-22. PMID:35992228. |
risks of digestive system side-effects of selective serotonin reuptake inhibitors in patients with depression: a network meta-analysis. |
2022-08-22 |
2023-08-14 |
Not clear |
| Zhuoyue Wang, Hui Li, Yimin Kang, Yanlong Liu, Ligang Shan, Fan Wan. Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis. Therapeutics and clinical risk management. vol 18. 2022-08-22. PMID:35992228. |
selective serotonin reuptake inhibitors (ssris) are the preferred treatments for depression. |
2022-08-22 |
2023-08-14 |
Not clear |
| Heather Bleacher, Lindsay Koerperich, Naomi Malam, Kristen DeSant. Are antipsychotics effective adjunctive Tx for patients with moderate-to-severe depression? The Journal of family practice. vol 71. issue 6. 2022-08-22. PMID:35994758. |
augmentation with second generation antipsychotics, especially aripiprazole and quetiapine, appears to be effective in patients with moderate-to-severe depression who have had a suboptimal response to a selective serotonin reuptake inhibitor or a serotonin-norepinephrine reuptake inhibitor (strength of recommendation [sor]: a, based on a systematic review of randomized controlled trials [rcts] and an individual rct). |
2022-08-22 |
2023-08-14 |
Not clear |
| Raymond W Lam, Hee-Kit Wong, Ramruttun A Kumarsing, Anna N Chua, Roger C Ho, Roger S McIntyre, Cyrus S H. Fluoxetine improves bone microarchitecture and mechanical properties in rodents undergoing chronic mild stress - an animal model of depression. Translational psychiatry. vol 12. issue 1. 2022-08-20. PMID:35987907. |
fluoxetine is a highly prescribed selective serotonin reuptake inhibitor (ssri) in the treatment of depression and is reported to be a risk factor for fractures. |
2022-08-20 |
2023-08-14 |
rat |
| Julie A Vignato, S Banu Gumusoglu, Heather A Davis, Sabrina M Scroggins, Wendy S Hamilton, Debra S Brandt, Gary L Pierce, Boyd A Knosp, Donna A Santillan, Mark K Santilla. Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia. Reproductive sciences (Thousand Oaks, Calif.). 2022-08-19. PMID:35984571. |
ssris may modulate preeclampsia risk and mechanisms, although further studies are needed to investigate the relationships between 5-ht and avp in depression and preeclampsia. |
2022-08-19 |
2023-08-14 |
Not clear |
| Charles W Beckett, Maria Victoria Niklison-Chiro. The role of immunomodulators in treatment-resistant depression: case studies. Cell death discovery. vol 8. issue 1. 2022-08-17. PMID:35977923. |
the first-line treatment for most cases of depression are selective serotonin reuptake inhibitors (ssris), such as sertraline, reboxetine and fluoxetine. |
2022-08-17 |
2023-08-14 |
Not clear |
| Sha Liu, Yujie Tong, Xiao Wang, Xin Yu, Yong X. Baseline cognitive functioning can predict the trajectory of acute treatment in first-episode major depressive disorder. European archives of psychiatry and clinical neuroscience. 2022-08-15. PMID:35969275. |
this study aims to investigate the role of cognitive function in the efficacy prediction of selective serotonin reuptake inhibitors (ssris) for depression patients and to further the understanding of the relationship between baseline cognitive function and depression trajectory. |
2022-08-15 |
2023-08-14 |
Not clear |
| Tony Kendrick, Susan Collinso. Antidepressants and the serotonin hypothesis of depression. BMJ (Clinical research ed.). vol 378. 2022-08-15. PMID:35970554. |
antidepressants and the serotonin hypothesis of depression. |
2022-08-15 |
2023-08-14 |
Not clear |
| Melodi A Bowman, Jorge A Gomez, Nathan C Mitchell, Anne M Wells, Melissa Vitela, Kyra M Clarke, Rebecca E Horton, Wouter Koek, Lynette C Daw. Faster Serotonin Clearance in CA3 Region of Hippocampus and Antidepressant-like Effect of Decynium-22 in Juvenile Mice Are Putatively Linked to Increased Plasma Membrane Monoamine Transporter Function: Implications for Efficacy of Antidepressants in Juveniles. Cells. vol 11. issue 15. 2022-08-12. PMID:35954298. |
selective serotonin reuptake inhibitors (ssris) are less efficacious in treating depression in children than in adults. |
2022-08-12 |
2023-08-14 |
mouse |
| Ana Salomé Correia, Nuno Val. Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways. International journal of molecular sciences. vol 23. issue 15. 2022-08-12. PMID:35955633. |
tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways. |
2022-08-12 |
2023-08-14 |
human |